锦州银行(00416.HK)筹划资产重组及内资股增资扩股 今早起停牌
锦州银行(00416.HK)今早(27日)起停牌,该行公布,经与有关各方论证和协商後,正在筹划的资产重组及内资股增资扩股事项属於重大资产重组事项。公布指,此事项尚存在不确定性,为维护投资者利益,保证公平信息披露,避免股价异常波动,应该行要求,其H股和境外优先股将会自今早起暂停买卖。
该行表示,认为筹划中的资产重组事项能够有效提高该行资产品质及内部精细化资本管理水准并进一步优化资产结构。此外,其内资股增资扩股事项能够提升资本充足率,有效提升该行风险抵御能力,强化公司治理水准,把控发展方向,建立健全内部治理机构,实现整体稳健经营提供保障,并进一步增强该行综合竞争实力,促进可持续发展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.